These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3201 related articles for article (PubMed ID: 18579353)
1. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353 [TBL] [Abstract][Full Text] [Related]
2. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; Remon JP; Foreman P; Vervaet C Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625 [TBL] [Abstract][Full Text] [Related]
3. Development of starch-based pellets via extrusion/spheronisation. Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467 [TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets. Hu LD; Liu Y; Tang X; Zhang Q Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948 [TBL] [Abstract][Full Text] [Related]
5. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability. Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837 [TBL] [Abstract][Full Text] [Related]
6. Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability. He H; Li H; Tang X Pharm Dev Technol; 2011 Jun; 16(3):212-8. PubMed ID: 20151942 [TBL] [Abstract][Full Text] [Related]
7. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion. Bando H; McGinity JW Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652 [TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium. Fu J; Wang X; Xu L; Meng J; Weng Y; Li G; He H; Tang X Int J Pharm; 2011 Mar; 406(1-2):84-90. PubMed ID: 21219996 [TBL] [Abstract][Full Text] [Related]
9. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55. Sauer D; Zheng W; Coots LB; McGinity JW Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147 [TBL] [Abstract][Full Text] [Related]
13. Effects of film coating thickness and drug layer uniformity on in vitro drug release from sustained-release coated pellets: a case study using terahertz pulsed imaging. Ho L; Cuppok Y; Muschert S; Gordon KC; Pepper M; Shen Y; Siepmann F; Siepmann J; Taday PF; Rades T Int J Pharm; 2009 Dec; 382(1-2):151-9. PubMed ID: 19716407 [TBL] [Abstract][Full Text] [Related]
14. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. Zeng XM; MacRitchie HB; Marriott C; Martin GP Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863 [TBL] [Abstract][Full Text] [Related]
15. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets. Abbaspour MR; Sadeghi F; Afrasiabi Garekani H Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701 [TBL] [Abstract][Full Text] [Related]
16. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics. Marinich JA; Ferrero C; Jiménez-Castellanos MR Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473 [TBL] [Abstract][Full Text] [Related]
17. Development of an enteric-coated pellet formulation of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections. Huyghebaert N; Snoeck V; Vermeire A; Cox E; Goddeeris BM; Remon JP Eur J Pharm Biopharm; 2005 Feb; 59(2):273-81. PubMed ID: 15661499 [TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets. Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529 [TBL] [Abstract][Full Text] [Related]
19. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions. Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393 [TBL] [Abstract][Full Text] [Related]
20. The influence of the extrusion die on pellet characteristics. Rabisková M; Weingartová D; Häring A Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]